Market Research Report
The Cardiopulmonary Bypass Component Ecosystem: Ninety-six Suppliers, Sixteen Countries, Twenty-five Subsystems
|Published by||Greystone Research Associates||Product code||960348|
Delivery time: 1-2 business days
|The Cardiopulmonary Bypass Component Ecosystem: Ninety-six Suppliers, Sixteen Countries, Twenty-five Subsystems|
|Published: September 14, 2020||Content info:||
Cardiopulmonary bypass (CPB) is a technique that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the body. The CPB pump itself is often referred to as a heart-lung machine or "the pump". Cardiopulmonary bypass pumps are operated by perfusionists, medically directed by anesthesiologists, and surgically directed by cardiac surgeons who connect the pump to the patient's body. CPB is a form of extracorporeal circulation.Cardiopulmonary bypass is commonly used in heart surgery because of the difficulty of operating on the beating heart. Operations requiring the opening of the chambers of the heart require the use of CPB to support the circulation during that period. The machine nourishes the blood cells and allows them to continue cellular respiration even through surgery. As the market for invasive cardiovascular procedures increases with an aging global population, we forecast this segment to grow at a modest but steady rate.